Finance

Lists
BNGO:NASDAQ
BioNano Genomics Inc
USD 1,75
+31,58%
(+0,42) 1D
15 Sep., 11:06:20 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BNGO...
Open
USD 1,31
High
USD 2,23
Low
USD 1,31
Mkt. cap
20,61 m
Avg. vol.
163,81 k
Volume
24,09 m
52-wk high
USD 2,23
52-wk low
USD 1,00
EPS
-USD 3,76
Beta
1,65
Shares outstanding
11,78 m
No. of employees
96
Open
USD 1,31
High
USD 2,23
Low
USD 1,31
Mkt. cap
20,61 m
Avg. vol.
163,81 k
Volume
24,09 m
52-wk high
USD 2,23
52-wk low
USD 1,00
EPS
-USD 3,76
Beta
1,65
Shares outstanding
11,78 m
No. of employees
96
News stories
From web sources and news partners
About BioNano Genomics Inc
CEOErik Holmlin
Employees96
Founded2003
HeadquartersSan Diego, Kalifornië, Verenigde State van Amerika
SectorHealth care
Websitebionano.com
Analyst ratings
Based on 1 analyst giving stock ratings to BNGO in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for BNGO in the last 3 months
Highest
Current USD 1,75
USD 4,00 (+128,57%)
Average
USD 4,00 (+128,57%)
Lowest
USD 4,00 (+128,57%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Maintained
USD 4,00
+128,6%
09/10/2026
Yi Chen
H.C. Wainwright
Buy
Reiterated
USD 6,00
+242,9%
04/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
7,37 m
7,95 m
6,69 m
8,17 m
Cost of goods sold
4,00 m
4,55 m
3,44 m
3,86 m
Cost of revenue
4,00 m
4,55 m
3,44 m
3,86 m
Research and development expenses
2,84 m
3,23 m
3,14 m
2,99 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9,06 m
8,71 m
8,01 m
8,54 m
Operating expense
11,91 m
11,94 m
11,15 m
11,53 m
Total operating expenses
15,90 m
16,49 m
14,58 m
15,39 m
Operating income
-8,54 m
-8,54 m
-7,90 m
-7,22 m
Other non operating income
-150,00 k
434,00 k
-547,00 k
-274,00 k
EBT including unusual items
-8,49 m
-7,90 m
-8,29 m
-7,42 m
EBT excluding unusual items
-8,49 m
-7,90 m
-8,29 m
-7,42 m
Income tax expense
14,00 k
35,00 k
10,00 k
7,00 k
Effective tax rate
-0,16%
-0,44%
-0,12%
-0,09%
Other operating expenses
-
-
-
-
Net income
-8,50 m
-7,93 m
-8,30 m
-7,42 m
Net profit margin
-115,42%
-99,77%
-124,17%
-90,85%
Earnings per share
-1,59
-0,03
-0,75
-0,60
Interest and investment income
268,00 k
276,00 k
223,00 k
146,00 k
Interest expense
-69,00 k
-72,00 k
-72,00 k
-70,00 k
Net interest expenses
199,00 k
204,00 k
151,00 k
76,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-6,11 m
-6,35 m
-5,54 m
-4,87 m
Gain or loss from assets sale
-
-
34,00 k
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme